Literature DB >> 8729626

The economic burden of lymphatic filariasis in northern Ghana.

J O Gyapong1, M Gyapong, D B Evans, M K Aikins, S Adjei.   

Abstract

The socio-economic impact of lymphatic filariasis was investigated in a rural community in northern Ghana, as part of a multi-country study. The entire community was followed up for a period of one full calendar year, to document episodes of acute adenolymphangitis (ADL), treatment seeking and the cost of treatment. Cases of chronic filarial disease identified at the start of the study were also visited every 3 months to monitor treatment seeking and the costs of treatment. The subjects, who were mainly subsistence farmers, were found to be materially very poor. The incidence of ADL, which lasted an average of 5 days, was found to be very high. Most of those affected were unable to perform their normal activities for much of the ADL episode. In general, most subjects with long-standing chronic disease, such as elephantiasis of the leg and hydroceles, tended not to seek treatment except when there was superimposed ADL. Some aspects of treatment seeking, the cost of treatment, the burden of the disease on the community, and the public-health implications are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8729626     DOI: 10.1080/00034983.1996.11813024

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  25 in total

1.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

2.  Histopathologic improvement with lymphedema management, Léogâne, Haiti.

Authors:  Susan F Wilson; Jeannette Guarner; Alix L Valme; Jacky Louis-Charles; Tara L Jones; David G Addiss
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

3.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

4.  Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.

Authors:  Alexander Yaw Debrah; Sabine Mand; Sabine Specht; Yeboah Marfo-Debrekyei; Linda Batsa; Kenneth Pfarr; John Larbi; Bernard Lawson; Mark Taylor; Ohene Adjei; Achim Hoerauf
Journal:  PLoS Pathog       Date:  2006-09       Impact factor: 6.823

5.  Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.

Authors:  K D Ramaiah; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

6.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

7.  Marriage, sex, and hydrocele: an ethnographic study on the effect of filarial hydrocele on conjugal life and marriageability from Orissa, India.

Authors:  Bontha V Babu; Suchismita Mishra; Abhaya N Nayak
Journal:  PLoS Negl Trop Dis       Date:  2009-04-21

8.  Physical disability and psychosocial impact due to chronic filarial lymphoedema in Sri Lanka.

Authors:  R S Wijesinghe; A R Wickremasinghe; Sriyani Ekanayake; M S A Perera
Journal:  Filaria J       Date:  2007-03-29

9.  National mass drug administration costs for lymphatic filariasis elimination.

Authors:  Ann S Goldman; Victoria H Guisinger; Moses Aikins; Maria Lourdes E Amarillo; Vicente Y Belizario; Bertha Garshong; John Gyapong; Conrad Kabali; Hussein A Kamal; Sanjat Kanjilal; Dominique Kyelem; Jefrey Lizardo; Mwele Malecela; Godfrey Mubyazi; P Abdoulaye Nitièma; Reda M R Ramzy; Thomas G Streit; Aaron Wallace; Molly A Brady; Richard Rheingans; Eric A Ottesen; Anne C Haddix
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31

10.  Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.

Authors:  Richard D Rheingans; Anne C Haddix; Mark L Messonnier; Martin Meltzer; Gladys Mayard; David G Addiss
Journal:  Filaria J       Date:  2004-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.